BTK and Miyoshi myopathy: Interestingly, IHC staining and CGH array revealed that BTK increased in MM cells compared to normal control cells, moreover, high BTK-expressing patients are associated with poor outcome in TT2 and TT3 cohorts suggesting that BKT may be a potential therapeutic target for MM.